Study of Oral Upadacitinib to Assess Change in Disease Activity and Adverse Events in Adult Participants With Ulcerative Colitis or Crohn's Disease

RecruitingOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

June 24, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Ulcerative ColitisCrohn's Disease
Trial Locations (14)

10380

RECRUITING

Inje University - Ilsan Paik Hospital /ID# 269995, Goyang-si

31151

RECRUITING

SoonChunHyang University Hospital Cheonan /ID# 270015, Cheonan-si

34943

RECRUITING

The Catholic University of Korea, Daejeon St. Mary's Hospital /ID# 267843, Daejeon

42415

RECRUITING

Yeungnam University Medical Center /ID# 269992, Daegu

42601

RECRUITING

Keimyung University Dongsan Hospital /ID# 269775, Daegu

44033

RECRUITING

Ulsan University Hospital /ID# 270006, Ulsan

61453

RECRUITING

Chosun University Hospital /ID# 269990, Gwangju

02447

RECRUITING

Kyung Hee University Hospital /ID# 270003, Dongdaemun-gu

03722

RECRUITING

Yonsei University Health System Severance Hospital /ID# 268865, Seoul

06273

RECRUITING

Gangnam Severance Hospital /ID# 270020, Seoul

06591

RECRUITING

The Catholic University of Korea, Seoul St. Marys Hospital /ID# 270014, Seoul

07441

RECRUITING

Hallym University Kangnam Sacred Heart Hospital /ID# 270013, Seoul

07985

RECRUITING

Ewha Womans University Medical Centre /ID# 269776, Seoul

04597

RECRUITING

Seoul Songdo Hospital /ID# 270009, Junggu

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY